Braskem (BAK) Receivables - Other (2009 - 2025)

Braskem (BAK) has reported Receivables - Other for 17 consecutive years, with $217.2 million the latest figure, recorded in Q4 2025.

• Quarterly Receivables - Other rose 60.19% year-over-year to $217.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $217.2 million (up 60.19% YoY) and the FY2025 annual result came in at $807.4 million, up 80.75% from the prior year.
• Receivables - Other rose to $217.2 million in Q4 2025 per BAK's latest filing, from $121.8 million in the prior quarter.
• Over the last five years, Receivables - Other for BAK reached as high as $434.1 million in Q4 2023 and fell as low as $111.5 million in Q2 2024.
• A 5-year average of $189.7 million and a median of $157.0 million in 2021 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2021 — Receivables - Other jumped 362.33% — and 2024, when it sank 68.76%.
• Year by year, Receivables - Other stood at $175.5 million in 2021, then decreased by 21.16% to $138.4 million in 2022, then surged by 213.69% to $434.1 million in 2023, then plunged by 68.76% to $135.6 million in 2024, then jumped by 60.19% to $217.2 million in 2025.
• According to Business Quant data, Receivables - Other over the past three periods registered $217.2 million, $121.8 million, and $135.6 million for Q4 2025, Q1 2025, and Q4 2024 respectively.